Epidemiology

M.J. Alter, H.S. Margolis,K. Krawczynski, F.N. Judson, A. Mares, W.J. Alexander, P.Y. Hu, J.K. Miller, M.A. Gerber, R.E. Sampliner, E.L. Meeks, M.J. Beach, "The natural history of community acquired hepatitis-C in the United States," New England Journal of Medicine, 327:1899-1905, 1992. (Total citations through October 1994: 76) This paper reports the results of a study tracking the onset and course of hepatitis C virus (H

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This paper reports the results of a study tracking the onset and course of hepatitis C virus (HCV) infection in patients over a four- to six-year period.

"We looked at the natural history of the disease--namely what happens over time with respect to infection and clinical symptoms," says Miriam Alter, chief of the epidemiology section of the hepatitis branch at the Centers for Disease Control and Prevention (CDC) in Atlanta. "We found that 62 percent of the patients developed chronic hepatitis and that all of them remained persistently infected even in the absence of liver disease or inflammation."

From an epidemiological perspective, this study proved significant, Alter explains, since "it showed that the majority of cases did not contract the disease from transfusions, which are believed to be the most common mode of spread. Most people get it [HCV] as a result of community-based exposure--sharing contaminated needles, for instance, or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Miriam Alter

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development